Achieve Life Sciences, Inc (ACHV) is a leading biotechnology business based in the US. It opened the day at $8.72 after a previous close of $8.66. During the day the price has varied from a low of $8.51 to a high of $8.83. The latest price was $8.61 (25 minute delay). Achieve Life Sciences is listed on the NASDAQ and employs 14 staff. All prices are listed in US Dollars.
Since the stock market crash in March caused by coronavirus, Achieve Life Sciences's share price has had significant negative movement.
Its last market close was $8.51, which is 14.90% down on its pre-crash value of $10 (accounting for the 31 July 2020 split) and 88.69% up on the lowest point reached during the March crash when the shares fell as low as $4.51 (accounting for the 31 July 2020 split).
If you had bought $1,000 worth of Achieve Life Sciences shares at the start of February 2020, those shares would have been worth $503.84 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $741.31.
|52-week range||$0.58 - $18.26|
|50-day moving average||$8.3615|
|200-day moving average||$8.7954|
|Wall St. target price||$45|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.606|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-01-14)||-5.28%|
|1 month (2020-12-22)||13.14%|
|3 months (2020-10-22)||-4.12%|
|6 months (2020-07-21)||-20.86%|
|1 year (2020-01-21)||-29.77%|
|2 years (2019-01-18)||-67.63%|
|3 years (2018-01-19)||-70.93%|
|5 years (2016-01-21)||-37.61%|
|Gross profit TTM||$0|
|Return on assets TTM||-42.31%|
|Return on equity TTM||-78.07%|
|Market capitalisation||$48.6 million|
TTM: trailing 12 months
There are currently 497,444 Achieve Life Sciences shares held short by investors – that's known as Achieve Life Sciences's "short interest". This figure is 6% down from 528,984 last month.
There are a few different ways that this level of interest in shorting Achieve Life Sciences shares can be evaluated.
Achieve Life Sciences's "short interest ratio" (SIR) is the quantity of Achieve Life Sciences shares currently shorted divided by the average quantity of Achieve Life Sciences shares traded daily (recently around 352797.16312057). Achieve Life Sciences's SIR currently stands at 1.41. In other words for every 100,000 Achieve Life Sciences shares traded daily on the market, roughly 1410 shares are currently held short.
However Achieve Life Sciences's short interest can also be evaluated against the total number of Achieve Life Sciences shares, or, against the total number of tradable Achieve Life Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Achieve Life Sciences's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Achieve Life Sciences shares in existence, roughly 80 shares are currently held short) or 0.0819% of the tradable shares (for every 100,000 tradable Achieve Life Sciences shares, roughly 82 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Achieve Life Sciences.
Find out more about how you can short Achieve Life Sciences stock.
We're not expecting Achieve Life Sciences to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Achieve Life Sciences's shares were split on a 1:20 basis on 31 July 2020. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Achieve Life Sciences shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Achieve Life Sciences shares which in turn could have impacted Achieve Life Sciences's share price.
Over the last 12 months, Achieve Life Sciences's shares have ranged in value from as little as $0.58 up to $18.26. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Achieve Life Sciences's is 1.4243. This would suggest that Achieve Life Sciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation aids in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.